Lazard Global Equity Franchise Fund C Acc CHF HedgedRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | -4.5 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 20/11/2024 | CHF 99.76 | |
Day Change | -0.46% | |
Morningstar Category™ | Other Equity | |
ISIN | IE000TZRKQH9 | |
Fund Size (Mil) 20/11/2024 | USD 984.54 | |
Share Class Size (Mil) 20/11/2024 | CHF 0.03 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 19/06/2024 | 0.80% |
Investment Objective: Lazard Global Equity Franchise Fund C Acc CHF Hedged |
The investment objective of the Fund is to aim to achieve long-term capital appreciation. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Matthew Landy 30/06/2015 | ||
John Mulquiney 30/06/2015 | ||
Click here to see others | ||
Inception Date 09/06/2023 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR EUR | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Lazard Global Equity Franchise Fund C Acc CHF Hedged | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Omnicom Group Inc | Communication Services | 7.27 |
Nexi SpA | Technology | 6.93 |
CVS Health Corp | Healthcare | 6.54 |
International Game Technology PLC | Consumer Cyclical | 6.42 |
Rentokil Initial PLC | Industrials | 5.07 |
Increase Decrease New since last portfolio | ||
Lazard Global Equity Franchise Fund C Acc CHF Hedged |